Abstract
HPV vaccination rates remain low: cancer prevention community needs to continue promoting the vaccine's safety and efficacy, say experts.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have